𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The critical need for defining preclinical biomarkers in Alzheimer's disease

✍ Scribed by Fiandaca, Massimo S.; Mapstone, Mark E.; Cheema, Amrita K.; Federoff, Howard J.

Book ID
124134821
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
862 KB
Volume
10
Category
Article
ISSN
1552-5260

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Structural MRI biomarkers for preclinica
Structural MRI biomarkers for preclinical and mild Alzheimer's disease
✍ Christine Fennema-Notestine; Donald J. Hagler Jr.; Linda K. McEvoy; Adam S. Flei πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 535 KB

## Abstract Noninvasive MRI biomarkers for Alzheimer's disease (AD) may enable earlier clinical diagnosis and the monitoring of therapeutic effectiveness. To assess potential neuroimaging biomarkers, the Alzheimer's Disease Neuroimaging Initiative is following normal controls (NC) and individuals w

Biomarkers for apoptosis in Alzheimer's
Biomarkers for apoptosis in Alzheimer's disease
✍ Maria Ankarcrona; Bengt Winblad πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 85 KB

## Abstract Alzheimer's disease (AD) affects millions of people worldwide and the number of AD cases will increase with increased life expectancy. Today there is no cure for this devastating and always lethal disease and therefore it is of great interest for patients, relatives and societies to fin